iCarbonX
2 known investors
Find your way into iCarbonX
iCarbonX (碳云智能) develops multi-omics testing and AI-based technologies — including ctDNA detection, silicon-based biochips, TCR peptide chips, and AI drug design — to support cancer neoantigen research, clinical diagnostics, new drug development, and health management. The company applies these platforms across precision testing, personalized therapy design, and biological-age/anti-aging health assessment.
Investors · 2
In the news
Frequently asked questions
- What does iCarbonX do?
- iCarbonX (碳云智能) develops multi-omics testing and AI-based technologies — including ctDNA detection, silicon-based biochips, TCR peptide chips, and AI drug design — to support cancer neoantigen research, clinical diagnostics, new drug development, and health management. The company applies these platforms across precision testing, personalized therapy design, and biological-age/anti-aging health assessment.
- Who are iCarbonX's investors?
- iCarbonX's investors include Quan Capital, Third Point Ventures.